BlackRock MuniHoldings Investment Quality Fund (MFL) At $14.78 Forms Top; Versartis, Inc. (VSAR) Had 6 Bullish Analysts

Among 12 analysts covering Versartis Inc (NASDAQ:VSAR), 6 have Buy rating, 1 Sell and 5 Hold. Therefore 50% are positive. Versartis Inc had 26 analyst reports since August 13, 2015 according to SRatingsIntel. The company was initiated on Tuesday, October 4 by Piper Jaffray. As per Thursday, April 7, the company rating was initiated by Northland Capital. On Friday, September 22 the stock rating was downgraded by Cowen & Co to “Market Perform”. The stock has “Outperform” rating by Credit Suisse on Tuesday, December 20. The rating was maintained by Canaccord Genuity with “Buy” on Friday, September 22. The company was downgraded on Monday, September 25 by Citigroup. SunTrust initiated it with “Buy” rating and $25 target in Friday, December 2 report. Canaccord Genuity maintained Versartis, Inc. (NASDAQ:VSAR) rating on Friday, July 28. Canaccord Genuity has “Buy” rating and $2800 target. Morgan Stanley maintained it with “Equal-Weight” rating and $3 target in Friday, September 22 report. The firm has “Underperform” rating given on Thursday, December 17 by Credit Suisse. See Versartis, Inc. (NASDAQ:VSAR) latest ratings:

25/09/2017 Broker: Citigroup Rating: Hold New Target: $3.0 Downgrade
22/09/2017 Broker: Citigroup Rating: Hold New Target: $3.0 Downgrade
22/09/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $28 New Target: $9 Maintain
22/09/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $17 New Target: $3 Maintain
22/09/2017 Broker: PiperJaffray Old Rating: Overweight New Rating: Neutral Downgrade
22/09/2017 Broker: Cantor Fitzgerald Rating: Overweight Old Target: $34 New Target: $14 Maintain
22/09/2017 Broker: SunTrust Old Rating: Buy New Rating: Hold Old Target: $25 Downgrade
22/09/2017 Broker: Cowen & Co Old Rating: Outperform New Rating: Market Perform Downgrade
22/09/2017 Broker: Barclays Capital Old Rating: Overweight New Rating: Underweight Old Target: $28 Downgrade
08/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $26.0 Maintain

BlackRock MuniHoldings Investment Quality Fund (MFL) formed multiple top with $15.22 target or 3.00% above today’s $14.78 share price. BlackRock MuniHoldings Investment Quality Fund (MFL) has $558.80 million valuation. The stock increased 0.68% or $0.1 during the last trading session, reaching $14.78. About 63,820 shares traded. BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL) has declined 3.95% since January 17, 2017 and is downtrending. It has underperformed by 20.65% the S&P500.

Investors sentiment decreased to 1 in Q3 2017. Its down 0.27, from 1.27 in 2017Q2. It worsened, as 6 investors sold BlackRock MuniHoldings Investment Quality Fund shares while 9 reduced holdings. 3 funds opened positions while 12 raised stakes. 4.70 million shares or 6.25% less from 5.02 million shares in 2017Q2 were reported. Guggenheim Ltd Liability Corp has invested 0.01% in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL). Northwestern Mutual Wealth Com accumulated 2,835 shares. Fifth Third Bank & Trust reported 2,692 shares stake. Advsr Asset Mngmt Incorporated reported 0.02% stake. Missouri-based Fincl Ser Corporation has invested 0.05% in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL). Raymond James Associate reported 0% stake. Cohen And Steers Inc reported 94,138 shares stake. Provise Mgmt Gp Limited Company has invested 0.04% of its portfolio in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL). Cambridge Inv Research Advsr invested in 20,849 shares. Pnc Services Group has 0% invested in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL) for 1,427 shares. First Advsrs Limited Partnership holds 0% of its portfolio in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL) for 76,569 shares. Stifel Fincl Corp accumulated 91,779 shares. First Republic Investment holds 0% of its portfolio in BlackRock MuniHoldings Investment Quality Fund (NYSE:MFL) for 13,474 shares. 2.12M were accumulated by Morgan Stanley. 13,957 are owned by Raymond James Na.

Since September 21, 2017, it had 0 insider buys, and 5 insider sales for $7.02 million activity. 2.13 million shares valued at $7.01M were sold by PERCEPTIVE ADVISORS LLC on Thursday, September 21. 1,326 shares valued at $3,381 were sold by Westberg Paul on Thursday, October 19. Another trade for 776 shares valued at $1,979 was sold by Ward Shane. $1,701 worth of Versartis, Inc. (NASDAQ:VSAR) was sold by Hislop Colin on Thursday, October 19. Shares for $3,381 were sold by Brumm Joshua T on Thursday, October 19.

The stock decreased 1.16% or $0.025 during the last trading session, reaching $2.125. About 337,144 shares traded. Versartis, Inc. (NASDAQ:VSAR) has risen 103.18% since January 17, 2017 and is uptrending. It has outperformed by 86.48% the S&P500.

Investors sentiment decreased to 1.29 in Q3 2017. Its down 0.10, from 1.39 in 2017Q2. It worsened, as 25 investors sold Versartis, Inc. shares while 24 reduced holdings. 35 funds opened positions while 28 raised stakes. 16.86 million shares or 34.93% less from 25.90 million shares in 2017Q2 were reported. Golub Gp Ltd accumulated 40,000 shares. The Netherlands-based Alpinvest Ptnrs Bv has invested 0.34% in Versartis, Inc. (NASDAQ:VSAR). Bb&T Securities Ltd Llc stated it has 0% in Versartis, Inc. (NASDAQ:VSAR). 28,520 are held by Art Ltd Company. Tudor Invest Et Al invested in 13,995 shares. Jane Street Group Ltd Liability Corp reported 130,000 shares. Point72 Asset Mngmt Lp holds 0% or 100,000 shares in its portfolio. Switzerland-based Swiss Fincl Bank has invested 0% in Versartis, Inc. (NASDAQ:VSAR). Moreover, Great West Life Assurance Com Can has 0% invested in Versartis, Inc. (NASDAQ:VSAR) for 4,500 shares. Citadel Lc owns 25,385 shares. Bridgeway Mngmt Inc accumulated 0.01% or 193,900 shares. Moreover, Laurion Cap Lp has 0% invested in Versartis, Inc. (NASDAQ:VSAR) for 206,475 shares. Manufacturers Life Company The holds 0% or 16,606 shares. Metropolitan Life Insur Comm Ny holds 23,257 shares or 0% of its portfolio. Aqr Mngmt Limited Liability Corp has invested 0% of its portfolio in Versartis, Inc. (NASDAQ:VSAR).

Versartis, Inc. operates as an endocrine-focused biopharmaceutical firm in the United States. The company has market cap of $76.10 million. The firm is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency. It currently has negative earnings. It develops drug candidates that it has licensed from Amunix Operating, Inc.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: